Goldman Sachs Group Inc has patented a solid pharmaceutical formulation containing misoprostol for cervical ripening, labor induction, and postpartum hemorrhage prevention. The dispersible tablet allows alternative routes of administration, with specific ingredients for sublingual or oral use. GlobalData’s report on Goldman Sachs Group gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Goldman Sachs Group, Digital lending was a key innovation area identified from patents. Goldman Sachs Group's grant share as of May 2024 was 60%. Grant share is based on the ratio of number of grants to total number of patents.
Pharmaceutical tablet for misoprostol administration
A recently granted patent (Publication Number: US12005041B2) discloses a pharmaceutical tablet containing misoprostol as the sole active ingredient, suitable for sublingual or oral administration as an immediate release tablet. The tablet comprises specific percentages of crospovidone, cross-linked polymer of carboxymethyl cellulose, starch, microcrystalline cellulose, and a flow agent, ensuring the total does not exceed 100 wt %. The tablet is designed for use in treatments such as cervical ripening or labor induction in pregnant women, with variations in disintegration time and water dispersion capabilities outlined in the claims.
The patent details various formulations of the pharmaceutical tablet, specifying the composition percentages of key ingredients like crospovidone, starch, and microcrystalline cellulose, along with the disintegration time and water dispersion properties. The tablet is free of extended release agents, ensuring immediate release upon administration. Additionally, the tablet's ability to disintegrate upon contact with a minimal amount of water and its dispersion characteristics in a specified timeframe are highlighted. The patent also emphasizes the tablet's suitability for specific medical applications, such as cervical ripening and induction of labor, catering to the needs of pregnant individuals.
To know more about GlobalData’s detailed insights on Goldman Sachs Group, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
